| Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC) (NCT04278222) | Shanghai Changzheng Hospital | 2020-02-10 |
| A Retrospective Validations Microsatellite Instability (MSI) Testing v Mismatch Repair (MMR) in Gastric Adenocarcinoma (NCT04232020) | Royal Cornwall Hospitals Trust | 2020-02-07 |
| Prehabilitation for Gastrectomy (NCT04223401) | National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | 2020-02-06 |
| A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment (NCT04178460) | Zai Lab (Shanghai) Co., Ltd. | 2020-02-03 |
| Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer (NCT04576858) | Rigshospitalet, Denmark | 2020-02-03 |
| Novel Approach to Surveillance of Gastric Lesions (NCT04251403) | New York Presbyterian Hospital | 2020-02-01 |
| Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma (NCT04202484) | RenJi Hospital | 2020-02-01 |
| Effect of Multi-modal Intervention Care on Cachexia in Patients With Advanced Cancer Compared to Conventional Management (MIRACLE) (NCT04907864) | Kil Yeon Lee | 2020-01-31 |
| SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma (NCT03950271) | Henan Cancer Hospital | 2020-01-20 |
| LITT and Pembrolizumab in Recurrent Brain Metastasis (NCT04187872) | University of Florida | 2020-01-10 |
| Nab-paclitaxel Combined With S-1 Treating Diffuse Type of Stage Ⅲ Gastric Cancer (NCT03977220) | Shanghai Zhongshan Hospital | 2020-01-01 |
| Research on Early Recurrence of Locally Advanced Gastric Cancer Based on CT Radiomics Prediction (NCT07683195) | Liu Yang | 2020-01-01 |
| A Real World Study of Laparoscopic Preservation of the Pylorus Gastrectomy (NCT04160962) | RenJi Hospital | 2020-01-01 |
| Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection (NCT04219332) | Fujian Medical University | 2019-12-31 |
| Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy (NCT04205097) | Ajou University School of Medicine | 2019-12-23 |
| Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG (NCT04878783) | University of Roma La Sapienza | 2019-12-20 |
| The Clinical Study of Adjuvant Chemotherapy on Intestinal and Urethral Flora in Patients With Gastric and Colon Cancer (NCT04198051) | The First Affiliated Hospital of Dalian Medical University | 2019-12-20 |
| Effect of Tumor Treating Fields (TTFields, 150 KHz) Concomitant with Chemotherapy As First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma (NCT04281576) | NovoCure Ltd. | 2019-12-19 |
| Gastrectomy With or Without Drainage (ADiGe)? (NCT04227951) | Azienda Ospedaliera Universitaria Integrata Verona | 2019-12-17 |
| A Clinical Study of HLX10 Combined With Chemotherapy Versus Placebo Combined With Chemotherapy for Neoadjuvant/Adjuvant Treatment of Gastric Cancer (NCT04139135) | Shanghai Henlius Biotech | 2019-12-12 |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) (NCT04198766) | Inhibrx Biosciences, Inc | 2019-12-10 |
| AG & IM in CA Stomach Protocol (NCT04184960) | Chinese University of Hong Kong | 2019-12-05 |
| Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study (NCT07211880) | Zero Helicobacter IGAN Network | 2019-12-05 |
| Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers (NCT03935893) | Udai Kammula | 2019-12-03 |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour (NCT04107142) | CytoMed Therapeutics Pte Ltd | 2019-12-01 |
| Safety and Efficacy of γδ T Cell Against Gastric Cancer (NCT02585908) | Beijing Doing Biomedical Co., Ltd. | 2019-12-01 |
| POF Versus FOLFOX Plus IP Paclitaxel in AGC (NCT04155671) | Fujian Cancer Hospital | 2019-12-01 |
| The Value of TFF3 in Diagnosis of Gastric Cancer (NCT03894384) | Assiut University | 2019-12-01 |
| Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors (NCT04116320) | Craig L Slingluff, Jr | 2019-11-21 |
| A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer (NCT04062058) | Jing Jin, M.D. | 2019-11-20 |
| Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer (NCT04005365) | Yijing He | 2019-11-20 |
| Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors (NCT04157985) | Dan Zandberg | 2019-11-15 |
| A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT04161781) | Memorial Sloan Kettering Cancer Center | 2019-11-12 |
| Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers (NCT05800418) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-11-04 |
| Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach (NCT04022109) | University of Latvia | 2019-11-01 |
| Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer (NCT04168346) | Helsinki University Central Hospital | 2019-11-01 |
| A Benefit Population Atlas of nICT Versus nCT for LAGC (NCT07098104) | Cheng Chen | 2019-11-01 |
| "Mechanisms and Biomarkers of Response and Resistance to Current Targeted Therapies in Gastric Cancer" (THERRES) (NCT05051423) | University of Medicine and Pharmacy Craiova | 2019-11-01 |
| An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (NCT03704077) | Bristol-Myers Squibb | 2019-10-31 |
| Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer (NCT03865810) | Grupo Español de Rehabilitación Multimodal | 2019-10-22 |
| Phase I Trial HIPEC With Nal-irinotecan (NCT04088786) | Stony Brook University | 2019-10-22 |
| Effects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal Surgery (NCT04147481) | Yi Liu | 2019-10-21 |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy (NCT04068896) | NGM Biopharmaceuticals, Inc | 2019-10-16 |
| Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer (NCT04250948) | Sun Yat-sen University | 2019-10-12 |
| Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions (NCT04835246) | Endofotonics Pte Ltd | 2019-10-07 |
| ERAS (Early Recovery After Surgery) Protocol After Laparoscopic Total Gastrectomy and Proximal Gastrectomy (NCT03079596) | Seoul National University Bundang Hospital | 2019-10-01 |
| Novel Screening Modality for Early Gastric Cancer (NCT04114006) | University of Alabama at Birmingham | 2019-10-01 |
| Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (NCT04082364) | MacroGenics | 2019-09-30 |
| Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer (NCT03766607) | Korean South West Oncology Group | 2019-09-30 |
| Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG (NCT04062656) | University Hospital, Essen | 2019-09-26 |
| Study to Evaluate the Safety of Nanoxel M Inj. (NCT04066335) | Samyang Biopharmaceuticals Corporation | 2019-09-18 |
| Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers (NCT04077372) | Stanford University | 2019-09-16 |
| An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients (NCT04099641) | OncXerna Theraputics, Inc. | 2019-09-11 |
| A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test (NCT06521528) | Novomics. Co., Ltd. | 2019-09-01 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies (NCT03941626) | Shenzhen BinDeBio Ltd. | 2019-09-01 |
| Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy (NCT04385316) | The First Affiliated Hospital with Nanjing Medical University | 2019-09-01 |
| Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction (NCT04660695) | Hospital del Rio Hortega | 2019-08-15 |
| Effect of Preoperative Immunonutrition in Upper Digestive Tract (NCT04027088) | Complexo Hospitalario Universitario de A Coruña | 2019-08-10 |
| The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma. (NCT04065282) | First Affiliated Hospital of Zhejiang University | 2019-08-06 |
| Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population (NCT04019808) | Fundación para la Investigación del Hospital Clínico de Valencia | 2019-07-30 |
| PD-1 Antibody + Apatinib Mesylate in 2+ Line Serum AFP-elevated Gastric Adenocarcinoma (NCT04006821) | China Medical University, China | 2019-07-25 |
| Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma (NCT03939962) | Henan Cancer Hospital | 2019-07-24 |
| Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients (NCT05400915) | Yonsei University | 2019-07-23 |
| Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies (NCT04149691) | Celon Pharma SA | 2019-07-19 |
| Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma (NCT03959293) | Federation Francophone de Cancerologie Digestive | 2019-07-17 |
| A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma (NCT03840967) | Shadia Jalal, MD | 2019-07-09 |
| A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer (NCT03829345) | Royal Marsden NHS Foundation Trust | 2019-07-02 |
| EGFR Monoclonal Antibody for Advanced Gastric Cancer (NCT04136600) | Shanghai Changzheng Hospital | 2019-07-01 |
| Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events (NCT04294589) | Assistance Publique - Hôpitaux de Paris | 2019-07-01 |
| Artificial Intelligence Versus Expert Endoscopists for Diagnosis of Gastric Cancer (NCT04040374) | Tokyo University | 2019-07-01 |
| Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study. (NCT03976739) | Xijing Hospital of Digestive Diseases | 2019-06-17 |
| Diagnostic Power Comparison Between VOCs and CTCs (NCT03958812) | Anhui Medical University | 2019-06-15 |
| Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors (NCT04234113) | SOTIO Biotech AG | 2019-06-13 |
| Advanced GC Multi-omic Characterization in EU and CELAC Populations (NCT04015466) | Fundación para la Investigación del Hospital Clínico de Valencia | 2019-06-12 |
| Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy (NCT04106167) | Fate Therapeutics | 2019-06-11 |
| Effect of Pneumoperitoneum on Remifentanil Requirements in the Surgical Pleth Index-guided Analgesia (NCT03788447) | Ajou University School of Medicine | 2019-06-04 |
| Personalized DC Vaccine for Postoperative Cancer (NCT04147078) | Sichuan University | 2019-06-01 |
| Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer (NCT03957564) | Affiliated Hospital of Qinghai University | 2019-05-28 |
| Study of Alofanib in Patients With Metastatic Gastric Cancer (NCT04071184) | Russian Pharmaceutical Technologies | 2019-05-26 |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients (NCT03745326) | National Cancer Institute (NCI) | 2019-05-16 |
| A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors (NCT03960060) | Shanghai PerHum Therapeutics Co., Ltd. | 2019-05-16 |
| Effect of Arterial Cannulation on the Continuous and Non-invasive Hemoglobin Monitoring (NCT03957486) | Ajou University School of Medicine | 2019-05-14 |
| Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours (NCT03620643) | Royal Marsden NHS Foundation Trust | 2019-05-09 |
| The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomy (NCT03960775) | Yonsei University | 2019-04-30 |
| Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor (NCT03985072) | Andes Biotechnologies | 2019-04-26 |
| A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors (NCT03872947) | Toray Industries, Inc | 2019-04-26 |
| A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma (NCT03890198) | First Affiliated Hospital Xi'an Jiaotong University | 2019-04-22 |
| Oral Nutritional Supplements Compared With Standard Diet in Postoperative Gastric Cancer Patients With Adjuvant Chemotherapy (NCT03654534) | Sun Yat-sen University | 2019-04-16 |
| Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community (NCT03793335) | National Taiwan University Hospital | 2019-04-14 |
| Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer (NCT03909997) | Hospital Dr Sotero del Rio | 2019-04-05 |
| Neoadjuvant Immunotherapy for Resectable Gastric Cancer (NCT03878472) | Qilu Hospital of Shandong University | 2019-04-01 |
| Fluorescence Image-Guided Lymphadenectomy in Robotic Gastrectomy (NCT03931044) | International Study Group on Minimally Invasive Surgery for Gastric Cancer | 2019-04-01 |
| Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients (NCT03874871) | Peking University | 2019-03-20 |
| Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma (NCT03801668) | Huazhong University of Science and Technology | 2019-03-08 |
| A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy (NCT03813784) | Jiangsu HengRui Medicine Co., Ltd. | 2019-03-07 |
| Frailty and Postoperative Outcomes After Gastric Cancer Surgery (NCT03568110) | Parc de Salut Mar | 2019-03-05 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |
| Effects of Multimodal Prehabilitation on Frail Elderly Patients Undergoing Elective Gastric Cancer Surgery (NCT06510088) | Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University | 2019-03-01 |
| Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. (NCT03784040) | National University Hospital, Singapore | 2019-02-21 |
| FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors (NCT03841110) | Fate Therapeutics | 2019-02-15 |